House bill proposes faster approval process for certain over-the-counter drugs
/ 1 min read
Table of Contents
Representative [Name not provided in source] introduced a bill in the House that would change how the Food and Drug Administration (FDA) handles nonprescription drugs.
Why it matters: If passed, this would change the regulatory timeline for drug companies looking to sell new products without a prescription.
Who it affects
- Pharmaceutical companies developing over-the-counter medications
This information comes from Congress.gov regarding a bill referred to the House; please consult the official text before relying on this information.
Agency: House
Source: Congress.gov — read the official document